Half-year report · Q2
9218.TEDINET S100U88E
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | −¥96m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥217m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | −¥147m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥496m | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥213m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥146m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥219m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥4.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥618m | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥823m | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥914m | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥914m | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥812m | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥660m | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥29m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥178m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥18m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥91m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥38m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥167m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥209m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-20 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.29 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41.78 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.96 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.4% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥572m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥27m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥25m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥11m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥26m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥109m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥350,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥330m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥26m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥476m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥153m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥31m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥36m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥135m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥450,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥198m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥53m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥369m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Deposits received | Prior1YearInstant | 5526000 | JPY |
| Deposits received | CurrentQuarterInstant | 26617000 | JPY |
| Provision for bonuses | Prior1YearInstant | 900000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 8750000 | JPY |
| Other cl | Prior1YearInstant | - | JPY |
| Other cl | CurrentQuarterInstant | 384000 | JPY |
| Current liabilities | Prior1YearInstant | 405858000 | JPY |
| Current liabilities | CurrentQuarterInstant | 948455000 | JPY |
| Long term loans payable | Prior1YearInstant | 212461000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 2211443000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 212461000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 2211443000 | JPY |
| Liabilities | Prior1YearInstant | 618319000 | JPY |
| Liabilities | CurrentQuarterInstant | 3159898000 | JPY |
| Capital stock | Prior1YearInstant | 540269000 | JPY |
| Capital stock | CurrentQuarterInstant | 540419000 | JPY |
| Capital surplus | Prior1YearInstant | 531349000 | JPY |
| Capital surplus | CurrentQuarterInstant | 531499000 | JPY |
| Retained earnings | Prior1YearInstant | 43432000 | JPY |
| Retained earnings | CurrentQuarterInstant | -158718000 | JPY |
| Treasury stock | Prior1YearInstant | -78000 | JPY |
| Treasury stock | CurrentQuarterInstant | -78000 | JPY |
| Shareholders equity | Prior1YearInstant | 1114973000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 913121000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 543000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 198463000 | JPY |
| Net assets | Prior1YearInstant | 1115516000 | JPY |
| Net assets | CurrentQuarterInstant | 1111585000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 1733835000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 4271483000 | JPY |
| Net sales | Prior1YTDDuration | 1304409000 | JPY |
| Net sales | CurrentYTDDuration | 2275812000 | JPY |
| Cost of sales | Prior1YTDDuration | 549696000 | JPY |
| Cost of sales | CurrentYTDDuration | 1389785000 | JPY |
| Gross profit | Prior1YTDDuration | 754712000 | JPY |
| Gross profit | CurrentYTDDuration | 886027000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 537999000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 982311000 | JPY |
| Operating income | Prior1YTDDuration | 216713000 | JPY |
| Operating income | CurrentYTDDuration | -96283000 | JPY |
| Interest income noi | Prior1YTDDuration | 3000 | JPY |
| Interest income noi | CurrentYTDDuration | 7000 | JPY |
| Dividends income noi | Prior1YTDDuration | - | JPY |
| Dividends income noi | CurrentYTDDuration | 2000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 16000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 309000 | JPY |
| Non operating income | Prior1YTDDuration | 20000 | JPY |
| Non operating income | CurrentYTDDuration | 319000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 1770000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 13317000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |